Israeli Innovation & Technology

Israeli-Italian nano-satellite launches medical experiments into space

The DIDO-3 unit will conduct four experiments on drug resistance in optimal microgravity conditions.

By Batya Jerenberg, World Israel News

The Israeli and Italian space agencies successfully launched a shoebox-size satellite into space Wednesday night that will run medical experiments by remote control, the Israeli Space Agency (ISA) announced Thursday.

Four “ground-breaking medical-scientific experiments” on the DIDO-3 nano-satellite will be managed by scientists from the Technion, Sheba Medical Center and the Hebrew University of Jerusalem in partnership with Italian researchers. The four will test drug resistance from a chemical, biological and medical perspective.

Doctors have been struggling for years with antibiotic-resistant bacteria, so-called “super-bugs” that have built up resistance to today’s medications. The UN estimates that millions of people will die in the coming decades if a solution isn’t found.

Prof. Ohad Gal-Mor, director of the Infectious Diseases Research Laboratory at Sheba told The Jerusalem Post on Thursday why experiments in outer space can help with this problem.

“At Sheba Medical Center, we already have preliminary data suggesting that micro-gravity reduces antibiotic resistance acquisition from experiments we performed on the ground using a special device that mimics micro-gravity conditions to some extent,” he said.

“Now we are able to repeat these results under ‘real’ micro-gravity conditions and see how the conditions in space affect this process.”

The DIDO series of nano-satellites were developed by Israeli-Swiss company SpacePharma, founded in 2012 to use the weightless conditions in space to research and develop new medications.

They contain miniaturized, end-to-end laboratories that can perform many kinds of medical experiments while being operated from anywhere in the world. The whole satellite weighs a mere 2.3 kilo (5.06 pounds).

According to ISA head Avi Blasberger, SpacePharma is the only commercial competition NASA has in conducting space-based lab research.

The DIDO-3 was one of some 50 nano-satellites from 13 countries that took off on a rocket launched from French Guyana. It is expected to begin emitting its first signals from space at 11:00 a.m. Israel time Thursday, and spend two months up in space.

Share
Published by
Batya Jerenberg
Tags: antibiotic resistant bacteria Israel Space Agency Israeli satellite

Recent Posts

  • World News

Families of US Oct. 7 victims ask for investigation in Washington

The more than a dozen family members who traveled to Washington for the State Department…

1 hour ago
  • Videos

WATCH: Lebanese reporter admits Israel never started wars against Arab neighbors

Lebanese reporter Marwan Qaddoum pushes back on painting Israel as the devil of the region,…

2 hours ago
  • Arab-Israeli Conflict

Sinwar’s notes reveal plans to film and broadcast Oct. 7 Hamas atrocities

The writings indicate that psychological warfare and media exposure were intended components of the assault,…

2 hours ago
  • Jewish Diaspora & Antisemitism

Italian mayor apologizes after nearly 100 Jewish educators cancel Italy trip over demand to condemn Israel

The planned visit was thrown into controversy when participants were asked to sign a statement…

2 hours ago
  • Israel News

More Judaism, more victory: Ben-Gvir seeks revamped IDF code of ethics

Ben-Gvir’s proposed changes take aim at omissions in the IDF code of ethics that have…

3 hours ago
  • Videos

WATCH: Protests can’t shake Jerry Seinfeld’s Israel support

Legendary Jewish comedian Jerry Seinfeld, never known for his politics, has defied Hollywood to stand…

3 hours ago